<!DOCTYPE html>

<html lang="en">
    <head>
       <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
        <title>Q.Med</title>
        <style type="text/css"> body {background-color: #FFF5EE;}</style>
        <center> <b><font size="12">Q.Med</font></b> </center>
       
        <center> 
            <p><a><h4>Complete and reliable medicine info</h4></a>
            </p>
	</center>
    </head>
    <body>
     
    	<p>
           1) Followed are most recently approved lung cancer medicines in 2019 and 2018.
        </p>
	
	<Li><a href="Keytruda Pembrolizumab 2019.pdf">Keytruda Pembrolizumab 2019</a></Li>
	<Li><a href="Rozlytrek Entrectinib 2019.pdf">Rozlytrek Entrectinib 2019</a></Li>
	<Li><a href="Tecentriq Atezolizumab 2019.pdf">Tecentriq Atezolizumab 2019</a></Li>
	<br>

        <Li><a href="Gilotrif Afatinib 2018.pdf">Gilotrif Afatinib 2018</a></Li>
	<Li><a href="Imfinzi Durvalumab 2018.pdf">Imfinzi Durvalumab 2018</a></Li>
	<Li><a href="Tagrisso Osimertinib 2018.pdf">Tagrisso Osimertinib 2018</a></Li>
       	<Li><a href="Vizimpro Dacomitinib 2018.pdf">Vizimpro Dacomitinib 2018</a></Li>
	<Li><a href="Vitrakvi Larothectinib 2018.pdf">Vitrakvi Larothectinib 2018</a></Li>
	<Li><a href="Lorbrena Lorlatinib 2018.pdf">Lorbrena Lorlatinib 2018</a></Li>
	<br>

	<p>
           2) Followed are some info related to kidney cancer: officially approved indications, doses, possible biomarkers, available diagnostic tools/kits, and results from clinical trials.
        </p>
	
	<Li><a href="Inlyta Axitinib.pdf">Inlyta Axitinib</a></Li>
	<Li><a href="Sutent Sunitinib.pdf">Sutent Sunitinib </a></Li>
	<Li><a href="Afinitor Everolimus.pdf">Afinitor Everolimus</a></Li>
        <Li><a href="Keytruda Pembrolizumab.pdf">Keytruda Pembrolizumab</a></Li>
	<Li><a href="Opdivo Nivolumab.pdf">Opdivo Nivolumab </a></Li>
	<Li><a href="Cabometyx Cabozantinib.pdf">Cabometyx Cabozantinib</a></Li>
       	<Li><a href="Yervoy Ipilimumab.pdf">Yervoy Ipilimumab</a></Li>
	<Li><a href="Bavencio Avelumab.pdf">Bavencio Avelumab</a></Li>
	<Li><a href="Votrient Pazopanib.pdf">Votrient Pazopanib</a></Li>
	
	<center><p>Q.med is devoted to provide free and authentic medical information. One way to help us is to donate to the hard work if you have the source.</p></center>
	<center><a href="mailto:q.med@yahoo.com"><img src="paypal.png"></a> </center>
        
   	<div>
 	<center><a href="https://jimcs1.github.io/github1/">Home</a>
	| <a href="mailto:q.med@yahoo.com">Contact us</a>
	| <a href="mailto:q.medicines@gmail.com">Suggestions</a>
	| <a href="drugproperties.html">For Doctors</a>
	| <a href="drugstd.html">For Researchers</a>
	| <a href="api.html">For Manufactures</a>
	| <a href="https://www.fda.gov/Drugs/InformationOnDrugs" title="FDA drug database">FDA drug database</a> 
	| <a href="https://www.ema.europa.eu/en/medicines" title="EMA medicines search">EMA medicines search</a>
	</center> 
	</div>
      
    	<p>
           Disclaimers: we are providing medinfo. It may have some errors, use it with your own risk, and we take none of the responsibilities. Please refer to official info you could find.
        </p>
    </body>
</html>
